Post Profile






REGULATION RETARDS PROGRESS: FDA chief says drug makers are gaming the system to slow generic compe…

REGULATION RETARDS PROGRESS: FDA chief says drug makers are gaming the system to slow generic competition; vows action.
read more

share

Related Posts


The FDA’s Muscular Dystrophy Debacle Shows Trying To Speed Drug Approvals Up Can Slow Them Down

Industries / Medical : The Medicine Show

The handling of the experimental drug eteplirsen reflects badly on its maker, Sarepta Therapeutics, and on the FDA. It points to some very fixable flaws in our drug regulation system, many of them involving the way that the FDA comm...

FDA Makes Progress in Inspecting Generic Drug Facilities, But….

Medical / Pharmaceutical : Pharmalot

Under pressure to validate the safety of the pharmaceutical supply chain, the FDA in recent years has inspected more facilities belonging to generic drug makers.

U.S. FDA moves to prevent Pharma from 'gaming' generic drug system

Health : Reuters: Health

WASHINGTON (Reuters) - The U.S. Food and Drug Administration moved on Wednesday to prevent pharmaceutical companies from "gaming" the system to block or delay entry of generic rivals.

FDA takes action to speed safety information updates on generic drugs

Health : Medical News Today

A proposed U.S. Food and Drug Administration rule would speed the dissemination of new safety information about generic drugs to health professionals and patients by allowing generic drug makers to use the same process as brand drug...

SO CRAZY, IT MIGHT JUST WORK! The FDA Commissioner’s Novel Plan for Cutting Drug Prices: Competition…

US Politics / Conservative : Instapundit

SO CRAZY, IT MIGHT JUST WORK! The FDA Commissioner’s Novel Plan for Cutting Drug Prices: Competition. Lower-priced generic drugs saved the health care system an estimated $254 billion in 2014. An FDA study has found that as the numb...

Comments


Copyright © 2016 Regator, LLC